$393.72 +0.92 (%) Regeneron Pharmaceuticals Inc - NASDAQ

Oct. 31, 2014 | 04:00 PM

Partner Headlines

  1. Stocks End Week On Fine Note; LinkedIn Surges On Earnings

    IBD | Oct. 31, 2014 | 16:29PM EST
  2. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD | Oct. 29, 2014 | 12:51PM EST
  3. Four Biotechs Lead Health Care Stocks In Big Cap 20

    IBD | Oct. 27, 2014 | 19:00PM EST
  4. Amgen Q3 Earnings Beat Estimates; Guidance Mixed

    IBD | Oct. 27, 2014 | 18:56PM EST
  5. Biotechs Show Fed Chief's Not Much Of A Stock Analyst

    IBD | Oct. 22, 2014 | 17:01PM EST
  6. Biogen Leads 5 Top Biotech Stocks As Earnings Loom

    IBD | Oct. 21, 2014 | 19:56PM EST
  7. Three Big Cap Leaders Remain In Buy Range

    IBD | Oct. 20, 2014 | 18:47PM EST
  8. UPDATE: Regeneron, Sanofi Report Commencement of Phase 3 Study Of Dupilumab In Patients With AD

    Benzinga | Oct. 20, 2014 | 07:06AM EST
  9. Regeneron's Eylea Tops Rivals

    IBD | Oct. 17, 2014 | 18:45PM EST
  10. Regeneron Eye Drug Beats Rivals While Amgen Sues

    IBD | Oct. 17, 2014 | 11:27AM EST
  11. Stocks Power Higher At Open; Regeneron Vaults On Eylea Trial

    IBD | Oct. 17, 2014 | 10:58AM EST
  12. Benzinga's Volume Movers

    Benzinga | Oct. 17, 2014 | 10:45AM EST
  13. EYLEA Injection Demonstrates Significantly Greater Gains In Visual Acuity than Both Bevacizumab And Ranibizumab In NIH-Sponsored Diabetic Macular Edema Study

    Benzinga | Oct. 17, 2014 | 07:01AM EST
  14. LinkedIn, YY Among 5 Stocks With Top Fundamentals

    IBD | Oct. 16, 2014 | 08:02AM EST
  15. Apple, McKesson Among Big Caps In Trading Range

    IBD | Oct. 13, 2014 | 18:38PM EST
  16. Wall St. Expects Solid Q3 Profit Despite Global Blues

    IBD | Oct. 6, 2014 | 17:46PM EST
  17. Medical Stocks End Week On High Note, Biotechs Lead

    IBD | Oct. 4, 2014 | 08:02AM EST
  18. Alibaba Among 5 Stocks With Superior Long-Term Growth

    IBD | Oct. 1, 2014 | 19:52PM EST
  19. Stocks Move To Session Lows; Regeneron Rises On Drug Data

    IBD | Sep. 30, 2014 | 15:04PM EST
  20. Biotech Stocks Rebound On Strong Earnings, New Drugs

    IBD | Sep. 29, 2014 | 18:32PM EST
  21. Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

    IBD | Sep. 29, 2014 | 18:32PM EST
  22. Acorda To Buy Civitas, Gains Parkinson's Disease Drug

    IBD | Sep. 24, 2014 | 13:27PM EST
  23. UPDATE: Morgan Stanley Reiterates On Regeneron Pharmaceuticals Inc Following DME Doc Event

    Benzinga | Sep. 18, 2014 | 10:51AM EST
  24. Stocks Erase Modest Gains; Netflix Gaps Below 50-Day Line

    IBD | Sep. 16, 2014 | 12:12PM EST
  25. Deutsche Bank Is Bullish On Gilead Sciences, Inc. And Other Biotech Stocks

    Benzinga | Sep. 16, 2014 | 08:19AM EST
  26. Stocks Show Modest Losses; Biotechs Pressured Again

    IBD | Sep. 11, 2014 | 14:46PM EST
  27. Stocks Hold Modest Gains; FleetCor Reverses Higher

    IBD | Sep. 10, 2014 | 14:53PM EST
  28. Stocks Turn Higher After Soft Start; U.S. Silica Jumps

    IBD | Sep. 10, 2014 | 13:25PM EST
  29. Novartis Drug Is Heartening

    IBD | Sep. 2, 2014 | 18:39PM EST
  30. Novartis, Regeneron Cardio Results Pump Up Wall St.

    IBD | Sep. 2, 2014 | 18:04PM EST
  31. Novartis, Regeneron Hit New Highs On Cardio Drugs

    IBD | Sep. 2, 2014 | 11:19AM EST
  32. Thin Gains Quickly Turn Mixed; Regeneron, Staples Surge Ahead

    IBD | Sep. 2, 2014 | 10:43AM EST
  33. UPDATE: Morgan Stanley Reiterates On Regeneron Pharmaceuticals Ahead Of Conference Call

    Benzinga | Sep. 2, 2014 | 09:36AM EST
  34. Nasdaq, S&P 500 Rise In Lackluster Session; Tesla Gains

    IBD | Aug. 29, 2014 | 15:12PM EST
  35. Nasdaq Leads Quiet, Pre-Holiday Session; NXP Breaks Out

    IBD | Aug. 29, 2014 | 13:35PM EST
  36. Amgen edges up on trial results

    IBD | Aug. 28, 2014 | 18:42PM EST
  37. Stocks Indexes Fall Modestly, Shaking Off Ukraine Unrest

    IBD | Aug. 28, 2014 | 15:03PM EST
  38. Economic Data Fuel Another All-Time High For S&P 500

    IBD | Aug. 26, 2014 | 15:36PM EST
  39. Qihoo, Regeneron Among 5 Stocks With Top Fundamentals

    IBD | Aug. 21, 2014 | 13:25PM EST
  40. Jazz, Celgene Lead Top 4 Drugmaker Profit Margins

    IBD | Aug. 18, 2014 | 13:46PM EST
  41. Drugmaker Q2 Profits Robust

    IBD | Aug. 5, 2014 | 18:51PM EST
  42. 4 Top-Rated Drugmakers Beat Q2 Earnings Estimates

    IBD | Aug. 5, 2014 | 18:30PM EST
  43. Deutsche Bank Raises Regeneron's Price Target To $425

    Benzinga | Aug. 5, 2014 | 15:30PM EST
  44. UPDATE: Regeneron Posts Upbeat Q2 Results

    Benzinga | Aug. 5, 2014 | 07:03AM EST
  45. Earnings Scheduled For August 5, 2014

    Benzinga | Aug. 5, 2014 | 05:34AM EST
  46. Len Schleifer's Science Focus Pays Off At Regeneron

    IBD | Jul. 31, 2014 | 14:12PM EST
  47. Stocks End Mixed; Akamai Falls, Yelp Rises After Hours

    IBD | Jul. 30, 2014 | 17:00PM EST
  48. Amgen Restructuring Plan, Q2 Earnings Send Stock Up

    IBD | Jul. 30, 2014 | 11:20AM EST
  49. Stocks Thrash Out A Mixed Open; Buffalo Wild Wings Crumples

    IBD | Jul. 30, 2014 | 10:31AM EST
  50. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD | Jul. 24, 2014 | 17:07PM EST
Trading Center